This year, there have been over 30,000 nominations for the awards.
The finalists this year are:
Vet of the YearAndrew Hayes, Towcester Equine Vets, TowcesterClare McCabe (pictured right), Claymill Veterinary Clinic, CookstownLaurence Behrens, Goddard Veterinary Group, Dagenham
Vet Nurse of the YearCaroline Jones, Battle Flatts Veterinary Surgery, YorkHelen Rooney, Pet Blood Bank, LoughboroughLesley Ramsey, Debenham Veterinary Practice, Stowmarket
Practice Support Staff of the YearRhiannon Lewis, Streatham Hill Vets, StreathamLaura Cameron, Lomond Veterinary Clinic, HelensburghLouise O’ Reilly, Vets4Pets, Llanrumney
Practice Manager of the YearKristen Lorimer, Blue House Veterinary Centre, Stoke-on-TrentLouise Newman, Blue Cross Vets, MertonNicki Ridgeway, Vets4Pets, Ridgeway
Practice of the YearHollybank Veterinary Centre, NorthwichLanes Vets, PoultonMilfeddygon Williams Vets, Gwynedd
The awards will be hosted at the Kimpton Clocktower Hotel, Manchester on 23rd March.
Bella von Mesterhazey, Sales & Marketing Director at Petplan, said: “This year’s finalist line-up includes an outstanding array of veterinary professionals and practices, and Petplan is delighted to be celebrating the highest achievements in pet healthcare once again."
Designed to be used as a tertiary cohesive layer, the Rapz Eazy Tear Natural World bandages, which are available in 5cm, 7.5cm and 10cm widths, can be torn without the need for scissors.
They are suitable for both large and small animals and Millpledge says they offer optimal protection and support for tendons and ligaments.
As part of the launch, Millpledge has pledged a total donation of £12,000 to Wildlife Vets International (WVI), a British charity that provides veterinary support to international wildlife and conservation projects.
Meryl Lang, Sales Manager at Millpledge, said: “Supporting conservation is an integral part of our vision for Rapz Easy Tear Natural World.
"With increasing threats faced by many species, from habitat loss and human conflicts to poaching and plastic pollution, more animals than ever are being classified as critically endangered.
"It’s fantastic to be able to contribute to such an important cause.”
For ore infornation, email enquiries@millpledge.com
Bimeda has announced the launch of Butagran Equi (phenylbutazone), to join its range of analgesics and anti-inflammatories.
Bimeda says that Butagran Equi provides rapid onset of activity with the added convenience for horse owners or professionals of being presented as an easy-to-administer sweetened powder.
Indications include musculo-skeletal conditions that require relief from pain and a reduction in the associated inflammation, including lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.
Head of Bimeda technical services Padraig Hyland MVB said: "Butagran Equi is particularly suited where continued mobility is considered desirable. It is also of value in limiting post-surgical inflammation, myositis and other soft tissue inflammation and can be used as an anti-pyretic where this is considered advisable, such as in viral respiratory infections. And being a sweetened powder it's quite straightforward for horse owners to administer and dose as prescribed."
He added: "Butagran Equi follows the launch of a number of new products and is proof our desire to provide a comprehensive and relevant equine portfolio backed up with first class technical support."
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
The College says that 1CPD has been designed to facilitate the new outcomes-focused CPD model which was introduced in 2020 and becomes mandatory from 2022.
An important part of this new model is reflection, so 1CPD encourages vets to reflect on the quality, relevance and impact of their CPD activities.
Dr Linda Prescott-Clements, RCVS Director of Education said: "Although the outcomes-focused element of these changes won’t become mandatory until January 2022, we recommend that you incorporate reflection in your cycle of planning, doing and recording CPD as soon as possible, and our new 1CPD app makes this much easier to do than before.
"Research has found that reflection enhances the quality, impact and relevance of CPD as professionals consider what they have learned, how they will apply their learning and how it will improve their practice. To support this CPD model, which research has shown has a positive impact on both professionalism and patient outcomes, the 1CPD platform facilitates reflection by allowing you to record your reflective notes on your recorded CPD activities, through a variety of means including text, audio or uploading a document."
The old PDR was taken offline last Friday and all of the data saved in the PDR has been transferred to 1CPD.
The 1CPD app is now available for both Apple and Android devices, available on and off line, and through a new dedicated website, all of which is now accessible using the same credentials used to access My Account.
Richard Burley, RCVS Chief Technology Officer, said: "1CPD provides a range of enhancements to RCVS’ previous offerings in this space and represents an important step forward in the College’s digital approach. Built on the latest best-practice technologies, it improves on every aspect of our previous approach to CPD support, delivering the first stage of a new, integrated, career-long CPD support capability for members.”
The launch of 1CPD also coincides with a change to the way that the College assesses CPD compliance, moving to an annual CPD requirement of 35 hours a year for veterinary surgeons and 15 hours a year for veterinary nurses.
More information on the CPD changes, along with accompanying resources, can be found on the RCVS website: http://www.rcvs.org.uk/cpd2020.
So that practices can make sure everyone in their team is aware of the changes, the RCVS has also produced a poster which can be downloaded at: https://www.rcvs.org.uk/news-and-views/publications/cpd-poster/.
For more information, contact the Education team on 0203 795 5595. For technical advice about 1CPD, email the RCVS at onecpd@rcvs.org.uk.
Krka’s Farm Key Account Manager Charlotte Read said: “BRD remains a priority issue on farm and advising farmers on the management of BRD risks, and treatment options when needed, is a key task for farm vets.
"Flovuxin’s combined formulation is a high efficacy BRD treatment acting within six hours1, to improve treatment outcomes.”
Reference
Davies Veterinary Specialists has announced that it will be launching a new referral service in the heart of London at an event being held at the Institute of Physics at 7:00pm on 15th February.
As part of the preparations, the multi-discipline referral centre has published a very polished video which you can view here.
The launch event includes some free CPD: "Challenges in Urology", together with drinks and nibbles.
The VCMS, which is administered by Nockolds Solicitors, was formally launched by the RCVS as an alternative dispute resolution service in October 2017 following a year-long trial.
The aim of the service is to resolve, by mediation, disputes between clients and veterinary practices that do not meet the threshold of serious professional misconduct that is needed for the RCVS to investigate a concern through its formal processes.
Since the service’s trial, which started in October 2016, the VCMS has given preliminary mediation advice on how to resolve a case in more than 1,700 instances with over 580 cases having gone to full mediation of which 89% have concluded with a resolution.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, said: "From the perspective of both the public and the profession, the establishment of the VCMS has been a "win-win" situation. For the public it has provided them with an additional route to solve those complaints which wouldn’t cross the threshold to progress in the concerns investigation process.
"For the profession it has provided a more appropriate format for resolving a client dispute that doesn’t involve the time, effort and formal process of an RCVS investigation for those cases that will never amount to serious professional misconduct. I think this has been demonstrated by the fact that the vast majority of the profession are willing to engage with the VCMS process, even though it is entirely voluntary.
"The VCMS has also had a positive impact on the College and its concerns investigation process, allowing us to focus greater resources on those cases that do meet our threshold of serious professional misconduct. This has had a very clear impact on the speed with which we either close cases or move them on to the next stage of consideration by the Preliminary Investigation Committee (PIC), which, again, is important to both the public and the profession."
The College says that around 90% of cases investigated at Stage 1 of the process are now either closed or referred to PIC within four months – the College’s key performance indicator at this stage. This compares to around 50% of these cases being closed or referred within four months at Stage 1 in 2016.
The College also says that in total (including both preliminary and full mediation cases), 86% of the cases dealt with by VCMS were successfully mediated and feedback from both clients and veterinary practices has been largely positive. In client feedback from the third quarter of 2018, 93% said they would use the VCMS again and 79% considered it to be fair, while the equivalent figure amongst veterinary practices was 94% and 87% respectively.
Jennie Jones, a partner at Nockolds Solicitors who heads up the VCMS, said: "It is a good sign that mediation is largely working as it should when both parties are reporting similar satisfaction rates and we pride ourselves on negotiating resolutions that are acceptable and beneficial for both the clients and the practices.
"It is great to see that our efforts are also having an impact on the RCVS concerns investigation system by allowing it to concentrate on more serious cases."
More information about the RCVS concerns investigation process, including the different stages of an investigation, can be found at www.rcvs.org.uk/concerns
Further information about the VCMS can be found on its website at www.vetmediation.co.uk or by calling 0345 040 5834.
The charity highlights that loneliness affects the mental wellbeing of many in the profession, from locums being away from friends and family, students away from loved ones, those who feel isolated at their practice, and vets worried about the lonely farmers they are supporting.
Vetlife Helpline Manager Rosie Allister said: “Every call to Vetlife Helpline is completely confidential and we would never speak or write about them, even anonymised, but we do hear themes around loneliness in our calls.
"It takes courage to acknowledge feeling lonely. There’s a stigma to it, and it’s often trivialised. Saying you’re lonely can feel like disclosing a vulnerability. People feel they need to hide it, to put on a façade.”
The new leaflet encourages those who are experiencing loneliness to open up if they are struggling and gives advice on how it can be combatted.
It can be downloaded here: https://www.vetlife.org.uk/mental-health/loneliness-isolation/
The new guide, developed in association with Vets Digital, is the latest addition to BVA’s ‘Respect your vet team – end abuse’ campaign, which aims to support vets and veterinary workplaces who experience abuse from animal owners either in person or online.
It will be added to the Respect Your Vet Team toolkit, which offers a range of resources designed to help protect staff and limit the frequency and impact of abuse from clients.
The resources include practical tips on how to protect staff from online abuse, downloadable posters encouraging respectful behaviour from clients and a series of blogs exploring the issues.
BVA President Malcolm Morley said: “The vast majority of clients are hugely appreciative of the care they receive from their vet teams, resulting in thousands of positive reviews every year.
"While we recognise not every client will have a positive experience and may wish to provide critical feedback, a small number are posting deliberately abusive or unfair reviews.
"This is unacceptable and can have a hugely negative impact on individual veterinary professionals and the wider team.
"Protecting the wellbeing of veterinary teams remains a top priority for BVA and this new resource will help vet teams to take practical steps to limit the impact of this type of abuse.”
https://www.bva.co.uk/resources-support/misc-resources/how-to-manage-unfair-and-abusive-reviews-online
All laying flocks that adhere to the British Lion Code of Practice must be vaccinated against Salmonella Enteritidis and Salmonella Typhimurium during the rearing period.
Environmental sampling is carried out to monitor the flocks for Salmonella infection from 22-26 weeks of age and continuing every 15 weeks throughout the laying period.
Version 8 of the British Lion Code of Practice states that approved Salmonella testing laboratories must undertake testing to differentiate between field and vaccine strains of Salmonella.
The Cevac Salmovac vaccine strain can occasionally be detected during routine sampling.
When this happens, the accredited laboratory can carry out the differentiation testing whilst also sending the samples to the official confirmatory laboratory for final identification.
Ceva says ASAP significantly improves and speeds up the differentiation between vaccine and field strains, providing early reassurance to the producer that the official confirmation will identify the vaccine strain.
The ASAP Salmonella differentiation test has 100% sensitivity and 100% specificity for differentiating the Cevac Salmovac vaccine strain from any Salmonella field strain.
Pippa Abbey, poultry national veterinary services manager at Ceva Animal Health said: “Several tests are available to differentiate Cevac Salmovac from Salmonella field strains, however using ASAP as a second medium significantly improves and speeds up the differentiation process, ensuring that laboratories can quickly and efficiently detect the presence of the Cevac Salmovac strain.
“The ASAP media is also a useful tool for monitoring Cevac Salmovac drinking water vaccination and helps with vaccination auditing.”
Ceva also says that using ASAP media as a tool for monitoring the application of its vaccine can provide reassurance that it has been given successfully.
On the day of vaccination, following priming of the drinker lines, a water sample can be taken from the end of the line and sent to the laboratory for testing.
Cevac Salmovac will grow in dark blue/purple colonies indicating vaccine availability throughout the poultry house and a good vaccination process.
BCF has announced the launch of the Medison Sonovet R3 portable ultrasound scanner.
BCF says the R3 is the next evolution of the Pico from Medison which is ideal for both equine and small animal vets. It is now more compact with a robust design with enhanced image quality and improved frame rate, and even at a lower price.
Graham Howe, Partner at Stow Veterinary Surgeons in Gloucestershire has one of the new machines. He said: "We chose the Medison R3 for several reasons. The R3 is an excellent quality machine at the right price and provides excellent value for money. We wanted Doppler and the R3 provides this without breaking the bank.
"The scanner has increased our diagnostic capabilities and enabled us to diagnose increasingly subtle lesions in small animal anatomy.
"We also knew from previous experience with previous with an ultrasound scanner and digital X-ray machine that we could rely on BCF for support."
For more information visit http://www.bcftechnology.com/, or call +44 (0)1506 460023 to arrange a demonstration.
In the study, which was supported by MSD and led by Rosie Lyle of Bishopton Veterinary Group, 18 farmers placed temperature loggers in the fridge where they normally store vaccines. Temperatures were then monitored between February and April. Throughout this period, 89% of loggers recorded a temperature outside the 2–8°C range at least once, and 43% recorded temperatures outside this range more than 50% of the time.
The authors say that these findings raise potential concerns about vaccine efficacy.
Rosie found that 55% of the loggers recorded a temperature over 8°C, and 39% recorded a temperature below 2°C.
Across all the fridges monitored, the maximum temperature recorded was 12°C and the minimum was -11.5°C.
Rosie said: "This is a surprisingly wide range. Obviously, these findings are concerning for farmers as we know that both too high and too low temperatures can impair vaccine efficacy.
"Live vaccines tend to be particularly sensitive to elevated temperatures, whereas inactivated vaccines are more affected by freezing, especially when the adjuvant contains aluminium salts".
"It’s important for both farmers and vets to be aware of potential concerns about vaccine efficacy, given the possible impact on herd health and the potential for vaccine failure to reduce trust in vaccines and herd health recommendations".
In light of Rosie’s findings, other XLVets practices are now encouraging farmers to take action to improve medicine storage, including using max/min thermometers or temperature loggers to track fridge temperature, as well as taking steps to maximise the efficiency of each fridge.
Susan Goodfellow, Marketing Manager at XLVets, said: "We wouldn’t have known that this is an important issue to highlight to farmers without collecting the information, so Rosie’s study was very valuable.
"In the XLVets community, we support clinical leadership with these kind of projects – we actively collect data and make sure that farmers can benefit from the latest findings. As a group of independent practices working together, we can achieve much more than we could in isolation."
A new survey by Petplan has given an insight into how veterinary nurses regard their job.
The survey, conducted at BVNA Congress, found that 73% of nurses feel that clients do not have a sufficient understanding of their role in practice.
Louisa Baker, the 2008 Petplan Vet Nurse of the Year, said: "Clients are often not aware of the skills required to be a vet nurse. Most clients believe we just handle the animals whereas we are often involved with surgical activities such as stitching and preparing drips."
Arguably, if pet owners under-appreciate the role of the nurse in practice, then they might also be expected to place a lower financial value on the care they provide. If that is the case, then it makes a lot of sense for vets and practice owners to find novel ways of communicating the breadth of work that nurses do, and its importance, to clients.
Other findings included 40% of nurses agreeing that direct contact with animals, such as caring for them through recovery, is the best part of the job. 54% told Petplan that they find the job extremely rewarding.
Nearly all nurses (99%) said that they value training and CPD to further their careers.
To support this desire to learn, Petplan has launched its Petplan Insurance Advisor training scheme. Already, over 500 nurses have completed one of the scheme's CPD qualifying modules.
The scheme enables the development of individual skills such as the ability to sell products and gain confidence with clients. Available online, vet nurses can participate in the scheme at work or at home. Visit http://www.petplanpia.co.uk/ for more information.
Dechra Veterinary Products is warning veterinary professionals it is experiencing supply issues with Oxyglobin, Haemoglobin Glutamer-200.
Dechra has supplied Oxyglobin under an exclusive UK distributor agreement with Biopure Corporation since 2002. In 2009, the assets of Biopure Corporation were acquired by OPK Biotech, which has its headquarters in Cambridge, MA, USA. OPK Biotech is working to resume manufacture of Oxyglobin as soon as possible but it is not expected this will happen until well into 2011.
Bob Parmenter, Managing Director of Dechra Veterinary Products, said: "Unfortunately we are now out of stock of Oxyglobin and, due to the supplier's manufacturing issues, we are unlikely to receive new supplies in the immediate future. I would like to apologise to veterinary professionals for any inconvenience this will cause to their practice but unfortunately this situation is out of our control. We have written to all our Oxyglobin customers to inform them of the position and will keep in contact to advise them when the situation has changed."
Dechra is advising veterinary professionals that the Pet Blood Bank may be able to offer an alternative product, while Oxyglobin is out of stock. The Pet Blood Bank can be contacted on 01509 232 222, Monday to Friday between 0830 and 1830. The organisation offers a same day and next day delivery service, along with an advice line. Full details of products and services are available by logging on to www.petbloodbank.org
Nockolds Solicitors was approved as the new administrator of the ADR trial by RCVS Council at its June 2016 meeting at Cardiff City Hall. The company was identified and approved by the RCVS Operational Board as meeting its requirements, a decision which the RCVS says has been welcomed by the Veterinary Defence Society and the British Veterinary Association, as well as receiving lay and consumer support.
The current trial, which was launched in November 2014 and is administered by Ombudsman Services, will come to a close by 1 October, when the new trial with Nockolds will start.
Nick Stace, RCVS Chief Executive and Secretary, said: "In order to be able to make an informed choice about how we wish to design and implement a permanent ADR scheme we wanted to ensure that we have as many different options and as much data as possible. It is very important that we get the permanent scheme right and this is why Operational Board made the decision to have a second trial. It was also clear that satisfaction levels from consumers for the previous trial were lower than we would have liked and that we therefore need to explore other options.
"It is important to note that this will not just be a re-run of the first trial with a different administrator – there will be some significant differences between this and our first trial with Ombudsman Services.
"First, this will be a truly alternative process as consumers will be able to access the trial directly rather than having to go through the College’s concerns process first.
"Second, this will be a process of mediation meaning that expert advisors from Nockolds will facilitate communication between the complainant and the veterinary surgeon to try and find a satisfactory solution to the concern."
The trial will be promoted to both the public and the profession as an alternative to the College’s formal concerns investigation process and participation in the trial will be voluntary. There will also still be a panel of veterinary advisors overseeing the trial and helping staff at Nockolds with any clinical queries they may have.
Jennie Jones is a Partner at Nockolds and will head up the trial. She said: "We are committed to providing a service that mediates complaints to find a fair, efficient and proportionate resolution. We are looking forward to working with everyone involved in veterinary profession to develop an effective mediation service that can be accessed by both the public and members of the profession.
"The service will focus on finding effective and practical resolutions. Understanding the root cause of the complaint and re-establishing effective communication are the crucial first steps in mediation and helping the parties to find a solution they can both accept. Over the coming months, we will be working with the RCVS, representative bodies for the profession and consumers to launch the service.
"In addition to mediating complaints, we will share insight in mediation and complaint resolution to inform practitioners and stakeholders and to enhance standards at veterinary practices. This enables complaint analysis to be used to help improve client care, avoid complaints and maintain trust and confidence in the profession."
A bespoke website for the trial will be set up in time for the launch on 1 October 2016.
Novartis Animal Health has launched a chewable formulation of Milbemax wormer, for dogs.
According to the company, clinical studies have shown that the chicken-flavoured formulation and chewy texture of Milbemax Chewable Tablets is highly palatable, with more than 94% of dogs showing spontaneous acceptance from hand. Novartis says this should help make worming simpler and improve compliance, something which is particularly important given market research which shows that difficulties in administering medications often leads to missed treatments.
Containing milbemycin oxime and praziquantel, the new tablets deliver the same broad spectrum efficacy as existing Milbemax formulations, effective for the treatment of roundworm, hookworm, whipworm, lungworm and tapeworm, and for the prevention of heartworm.
Folkert Kamphuis, Chief Operating Officer at Novartis Animal Health said: "The new EASYCHEW™ formulation represents Novartis Animal Health's latest innovation. It will make worming a treat whilst providing tried-and-trusted Milbemax efficacy. With Milbemax chewable tablets we give pet owners a wormer that is easy to administer and veterinarians the trusted efficacy of Milbemax."
Milbemax Chewable Tablets are available for both dogs and puppies, in four and forty-eight tablet packs.
Vetark has launched Aqua-Sed, a fish anaesthetic which has obtained the first permit for use as a fish euthanasia product.
Vetark says the new product enables the humane euthanasia of seriously ill or severely injured fish, as well as being a sedative to facilitate fish handling.
The new product incorporates a dosing pump to ensure accurate dosing, a critical aspect of fish anaesthetics.
The 250ml bottle and pump will be on sale at £13.13+VAT and is available under the Small Animal Exemption Scheme from Vetark.
Further information on fish anaesthesia visit the Vetark website on www.vetark.co.uk
The Veterinary Benevolent Fund (VBF) has announced the retirement of its President Dr. Lydia Brown, who had served the maximum of nine years as a trustee and member of the VBF Board.
Lydia became a director of the VBF following the merger of the Fund with the Vet Helpline (VHL) and the Veterinary Surgeons' Health Support Programme (VSHSP) in January 2005.
A past-president of the Royal College of Veterinary Surgeons (RCVS) and former chairman of the RCVS Trust, Lydia was a driving force behind the establishment of the VSHSP in 1999. This support programme was developed in response to the genuine need for a confidential service to treat veterinary surgeons with a wide variety of addictive conditions. Since then she has been involved in the expansion of the Helpline service from a telephone service to an increasingly-widely used email service.
The charity says that it is as a result of Lydia's thoroughness, sympathy and understanding, that very many veterinary surgeons and veterinary nurses have been helped to recover from many forms of addictive conditions and health problems.
BSAVA President Sue Paterson said: "By signposting clients to extra downloadable advice or handing them a printed guide when they leave consultation room, we will hopefully reduce their temptation to run potentially misleading ‘Dr Google’ searches to find out more about the diagnosis."
The series includes:
My dog does not like other dogs
My dog has dental disease
My dog has diabetes
My dog has itchy skin
My dog has kidney disease
They join the PetSavers existing library of general online guides on Puppies, Kittens, Rabbits, Guinea pigs, Caring for your elderly pet and Losing your pet.
Printed versions of the new guides can be ordered by veterinary practices to use in their reception areas, in exchange for a donation to PetSavers.
The new guides can be downloaded at http://www.petsavers.org.uk/Pet-guides
Amanda Melvin, Marketing Manager for the Companion Animal Team at MSD Animal Health said: "Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis1 so we want to do everything we can to prevent any further increases in this figure.
"Recent circumstances have put most practices under a great deal of strain and it's become clear from the increase in calls we're receiving that there is a high demand for more information and resources to support the care of diabetic pets.
"We've therefore decided that with Pet Diabetes Month in November, our best way of supporting veterinary practices is to make them aware of, and know how to access the resources we have available to help them."
The diabetes resources include veterinary nurse clinics and training, getting the most out ofVetPen, monitoring support tools and case advice.
Veterinary professionals can subscribe for access to the materials as individuals or as a practice team.
For further information, visit https://www.msd-animal-health-hub.co.uk/ahp/caninsulin/tools.
References
Fort Dodge Animal Health has announced that its Duvaxyn WNV vaccine against West Nile Virus (WNV) is now available in the UK, following its licensing through the European Medicines Agency (EMEA).
Duvaxyn WNV is the first vaccine available in Europe to protect horses against this emerging disease threat. 288 horses and two people in Italy were found to be infected with WNV during the outbreak that hit northern Italy in late 2008 where it is now considered endemic. The disease is endemic in all areas of North America where it has claimed the lives of both horses and humans.
West Nile Virus is caused by a highly contagious flavivirus, which is transmitted by mosquitoes, primarily of the Culex species. The natural hosts of West Nile virus are birds, with migratory birds from Africa carrying the disease. Mosquitoes become infected after taking a blood meal from infected birds and then may transmit the disease to horses and even humans. While horses are 'dead end hosts,' the consequences can be severe as the virus causes encephalitis or meningitis. Mortality rates among horses which develop neurological signs are high and there is no palliative cure for the disease. Treatment is limited to symptomatic relief which can be long and expensive.
Sabrina Jordan, UK Business Manager for Equine Vaccines at Fort Dodge said: "WNV is an increasing threat to the equestrian sector in the UK and is a particular challenge for owners who transport their horses around the world.
"The fact that a vaccine is now available will undoubtedly offer peace of mind to the equestrian community. They can be reassured that horses in the UK can now be vaccinated against WNV with a vaccine that has already been shown to be highly effective in protecting horses in America.
"With any vaccine, a record that a horse has been vaccinated with Duvaxyn WNV should be recorded in its horse passport. By presenting this vaccine in pre-filled syringes with Infovax-ID labels, we've aimed to make both the administration and record keeping of Duvaxyn WNV as convenient as possible.
"To build understanding of this potentially fatal disease threat, we are continuing to work with governments and authorities at a national and European level, as well as working in partnership with the UK's veterinary community to ensure that owners are fully informed about the risk WNV poses and of the benefits of vaccination."
The British Equine Veterinary Association (BEVA) and the British Association of Equine Dental Technicians (BAEDT) have joined forces to set recognised standards for equine dental treatment.
The two organisations are working in association with the RCVS, BVA, BVDA, WWAED and LANTRA to develop National Occupational Standards that will pave the way to allowing equine dental technicians the freedom to work within the Law under an Exemption Order. This should make it safer and easier for owners to source the most suitable dental treatment for their horses.
Currently all equine dental care falls within the Veterinary Surgeons Act 1966 (VSA) and should only be carried out by veterinary surgeons. Equine vets from BEVA and equine dental technicians from the BAEDT have been trying to address this anomaly with government for many years. In 2004 the organisations drew up a list (revised in 2009) of procedures that could be safely carried out by suitably qualified equine dental technicians and a list of those which should only be carried out by qualified veterinary surgeons because they involve sensitive tissues.
The envisaged Exemption Order will also provide better protection for horses and their owners by reinforcing the fact that only suitably qualified individuals are allowed to carry out equine dental care and treatments. While unqualified individuals should become easier to identify under the proposed new scheme, those qualified will also be held to account if their performance is not up to scratch.
The first step towards the Exemption Order is the drawing up of National Occupational Standards for Equine Dental Technicians. It is hoped that these will be formalised by LANTRA in early 2013.
Keith Chandler, BEVA President said: "After many years of working closely with the BAEDT on the continuing education and qualification of its members, we are thrilled that progress is finally being made towards an Exemption Order."
BAEDT Chair, Gemma Lilly, said: "BAEDT and its membership is very happy to be a key part of the team that hopes to put the Exemption Order in place - it will be good news for equine dental technicians, horse owners, and their animals."
Equine Dental Technician and member of the Worldwide Association of Equine Dentists, Martin Brookes, also supports the initiative. He said: "This will be a really important step forward for responsible Equine Dental Technicians. It will further improve the working relationships between EDTs and vets and help to protect the welfare of the horse."
As part of the partnership between the two companies, anyone who takes part in one of Improve's CPD courses in 2018 will be entitled to 6 months' half-price pet insurance from Agria.
Online Bitesize CPD modules cover topics including: cardiology, ophthalmology, small animal medicine, feline medicine and exotic animals. Modules are 20, 40 or 60 minutes in length and provide veterinary professionals with interactive experiences which count toward annual CPD requirements in short convenient bursts, earning digital badges and certificates to demonstrate total CPD achieved.
Nick White, Head of Veterinary Channel at Agria, said: "We’re delighted that our partnership with Improve International will give veterinary professionals free, instant access to high-quality and engaging CPD. Not only are the modules available varied and highly relevant, the 'bitesize' nature of the training makes it extremely convenient for busy practice staff to access.
"This is a great incentive for any practices not yet working with Agria to get onboard. As well as benefitting from free CPD, practices will also be working with a specialist lifetime insurer offering 5 weeks free insurance policies and much more for clients and their pets."
For more information, contact your Agria Business Development Manager or visit: www.agriapet.co.uk/bitesize and complete the Contact Us section, using 'FREE CPD' in the subject line of the enquiry box.
The Disciplinary Committee of the Royal College of Veterinary Surgeons has postponed judgment on sanction for 12 months in the case of a Hampshire veterinary surgeon found guilty of serious professional misconduct for cumulative failures to provide adequate professional care, and insufficient regard for animal welfare whilst treating a dog.
At a hearing which concluded last Thursday, Peter Ardle MacMahon MRCVS faced a six-part charge after working as a locum for Vets Now at North End in Portsmouth where, on the night of 14/15 July 2009, he treated Wilfred, a Cocker Spaniel who had ingested broken glass along with raw mince.
The Committee found that, having decided that surgery was an appropriate treatment, Mr MacMahon had not removed the glass identified on a radiograph. Nor had he even superficially searched the stomach contents he had evacuated to check that a large piece of glass he had previously identified on the radiograph had been removed. He had also not taken adequate steps to prevent contamination of Wilfred's abdominal cavity prior to the incision to the stomach.
Mr MacMahon admitted he knew there had been considerable spillage of stomach contents into Wilfred's abdomen. The Committee found that, with this knowledge, for Mr MacMahon to use only 250ml of fluid to lavage the abdomen was inadequate. This contributed to the Spaniel developing chemical peritonitis which might have developed into septic peritonitis but for a second operation the next morning, after the dog had been returned to the care of his usual veterinary practice. The Committee also expressed concern that Mr MacMahon had failed to effectively communicate the abdominal contamination to Wilfred's usual vets when he was handed back into their care.
Taken as individual allegations, these would not, in the opinion of the Committee, constitute serious professional misconduct. However, the Committee was of the view that, taken cumulatively, the charges were proved, and therefore the treatment given to Wilfred, fell far short of the standard to be expected in the profession.
When considering mitigating and aggravating factors, the Committee accepted that Mr MacMahon and the veterinary nurse assisting him were unfamiliar with the premises in which they were working, resulting in a difficulty in locating important equipment, and there were also multiple urgent cases during the evening the operation took place. The Committee also noted that 17 months had passed since the operation, and no further complaints against Mr MacMahon had been received by the RCVS.
The Committee further took into account that Mr MacMahon had little recent experience, having returned to practising veterinary medicine in January 2009, following almost ten years spent outside the veterinary profession. During this hiatus he undertook no continuing professional development (CPD), and completed only a five-week period of supervised practice prior to re-entering the profession.
Mrs Caroline Freedman, Chairman of the Disciplinary Committee said: "The Respondent placed himself in this situation: he knew that he had been out of practice for ten years, had not done any formal CPD during that time and chose to accept an appointment to work as a locum in a sole-charge out-of-hours emergency clinic. A foremost aggravating factor is that animal welfare was adversely affected. A non-critical patient was placed at risk by the Respondent's failures."
The Committee reiterated that the purpose of sanctions was not to be punitive, but to protect animal welfare, to maintain public confidence in the profession and to maintain professional standards. "A postponement of judgment, with suitable undertakings from the Respondent, is the correct course of action," said Mrs Freedman. Mr MacMahon has subsequently signed undertakings relating to CPD in both surgical and medical disciplines, and the Committee has postponed for 12 months its judgment as to any further sanction.